BioAge Labs (BIOA) Change in Receivables (2025 - 2026)
BioAge Labs (BIOA) reported Change in Receivables of -$60000.0 for Q1 2026, down 116.62% on a YoY basis from $361000.0 in Q1 2025, and down 123.62% sequentially from $254000.0 in Q4 2025.
BioAge Labs (BIOA) Change in Receivables (2025 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 2 years of Change in Receivables data on file, last reported at -$60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 116.62% year-over-year to -$60000.0; the trailing twelve-month figure through Mar 2026 stood at $348000.0 (down 3.6% YoY), and the FY2025 full-year result was $769000.0, changed N/A from the prior year.
- Change in Receivables fell to -$60000.0 in Q1 2026, from $254000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $361000.0 in Q1 2025 to a low of -$88000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | -60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | 254,000.00 |
| Dec 31, 2025 | 254,000.00 |
| Sep 30, 2025 | -88,000.00 |
| Sep 30, 2025 | -88,000.00 |
| Jun 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 242,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Mar 31, 2025 | 361,000.00 |